© John Wiley & Sons Ltd
Edited By: David Morgan, Thomas Permutt and Jorgen Seldrup
Impact Factor: 1.235
ISI Journal Citation Reports © Ranking: 2015: 45/123 (Statistics & Probability); 209/255 (Pharmacology & Pharmacy)
Online ISSN: 1539-1612
Welcome to the new Editor-in-Chief
We are delighted to welcome Jorgen Seldrup as one of three Editors-in-Chief of Pharmaceutical Statistics.
As a seasoned Statistician, Jorgen has gained much experience since obtaining his postgraduate degree in Statistics from Aarhus University, Denmark, in 1971. His career started in January 1970 as the first statistician at Geigy UK Ltd, followed by five years with a Paris-based CRO prior to joining Quintiles in 1994.
He has also worked in Singapore as Director of the Clinical Trials & Epidemiology Research Unit (CTERU), Ministry of Health, and was responsible for creating disease registry, and was a member of the National Medical Research Council, Adjunct Associate Professor at the National University of Singapore, and an External Examiner, University of Hong Kong.
He returned to Quintiles in 2003 and joined the Centre for Statistics in Drug Development in 2006. He retired in mid-2012 and set up his own statistical consulting company, jStatConsult.
He is an honorary member of PSI (Statisticians in the Pharmaceutical Industry which he founded in 1977 and became its first chairman) and ISCB (International Society for Clinical Biostatistics of which he was President 1992-94).
Recently Published Articles
- Statistical issues in first-in-human studies on BIA 10-2474: Neglected comparison of protocol against practice
Sheila M. Bird, Rosemary A. Bailey, Andrew P. Grieve and Stephen Senn
Version of Record online: 16 FEB 2017 | DOI: 10.1002/pst.1801
- Analyzing multiple endpoints in a confirmatory randomized clinical trial—an approach that addresses stratification, missing values, baseline imbalance and multiplicity for strictly ordinal outcomes
Hengrui Sun, Atsushi Kawaguchi and Gary Koch
Version of Record online: 11 JAN 2017 | DOI: 10.1002/pst.1799
- You have full text access to this OnlineOpen articleMisspecification of at-risk periods and distributional assumptions in estimating COPD exacerbation rates: The resultant bias in treatment effect estimation
M. Law, M.J. Sweeting, G.C. Donaldson and J.A. Wedzicha
Version of Record online: 14 DEC 2016 | DOI: 10.1002/pst.1798